A study of MGA271 in Combination with pembrolizumab and in combination with MGA012 in Patients with Melanoma, Squamous Cell Cancer of the Head and Neck, Non-Small Cell Lung Cancer, Urothelial Cancer, and other cancers (CP-MGA271-03)
A study of MGA271 in Combination with pembrolizumab and in combination with MGA012 in Patients with Melanoma, Squamous Cell Cancer of the Head and Neck, Non-Small Cell Lung Cancer, Urothelial Cancer, and other cancers (CP-MGA271-03)
Trial Category:
Head and Neck
Phase
I
Contact(s)
Location(s)
Nebraska Cancer Specialists, Omaha, NE
